Search

Crystalline Forms of Formula (I) Compounds for Cancer Treatment

The USPTO granted Patent US12606553B2 to Foghorn Therapeutics Inc., covering crystalline forms of a formula (I) compound and compositions containing those forms. The patent also protects methods of using the crystalline forms for treating cancer in subjects, including administration of an effective amount of the compound. The patent, classified under CPC C07D 417/14 (organic chemistry, heterocyclic compounds), contains 11 claims.